Prospective Metabolic Surgery in T2DM Chinese Subjects
A Prospective, Multi-Center Study for the Evaluation of Metabolic Surgery in Subjects With Type 2 Diabetes in China
Sponsor: Ethicon Endo-Surgery
A NA clinical study on Diabetes and Obesity, this trial is completed. The trial is conducted by Ethicon Endo-Surgery and has accumulated 15 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Apr 2025 — Present [monthly]
Completed NA
-
Feb 2025 — Apr 2025 [monthly]
Completed NA
-
Jan 2025 — Feb 2025 [monthly]
Completed NA
-
Sep 2024 — Jan 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
▶ Show 10 earlier versions
-
Jul 2023 — Jul 2024 [monthly]
Completed NA
-
Jun 2021 — Jul 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
May 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Oct 2019 — Nov 2020 [monthly]
Active Not Recruiting NA
-
Sep 2018 — Oct 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
-
Apr 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ethicon Endo-Surgery
For direct contact, visit the study record on ClinicalTrials.gov .